NCT00554788
Clinical Trial Information
Trial Number: NCT00554788 (ClinicalTrials.gov)
Disease Type:
- Eye Neoplasm - Retinoblastoma
Trial Title:
"A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma"
Study ID:
ARET0321
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00554788-D2 | NCT00554788-D2: There are 2 datasets associated with the PMID 35820112: NCT00554788-D1 through NCT00554788-D2. This dataset, NCT00554788-D2, provides the information for grade 3 and higher nonhematologic adverse events of evaluable patients after induction or after consolidation cycle 1 (Table A2). The number of rows per patient is dependent on the number of adverse events submitted. |
| NCT00554788-D1 | NCT00554788-D1: There are 2 datasets associated with the PMID 35820112: NCT00554788-D1 through NCT00554788-D2. This dataset, NCT00554788-D1, provides the eligibility criteria for all enrolled patients and the demographic, diagnostic, treatment details, responses, and data for all primary analyses of evaluable patients (Figure 2, Table 1, Table 2, Figure 3, Table A1). There is one row per patient. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®